Trade Wars & Tariffs

Academy Securities adds a special ops general to its roster, highlighting a major trend: the fusion of military strategy and high finance for market dominance.

Cricket legend Sachin Tendulkar is the new face of Techno Paints as the firm eyes a Rs. 500 crore IPO and aims to challenge giants in India's paint market.

The first-ever Wegovy pill is now available via telehealth platform Ro, offering a cash-pay option that could revolutionize access to weight loss drugs.

With new federal guidelines backing whole foods, programs delivering 'prescription produce' are proving they can cut healthcare costs and fight chronic disease.

A new report reveals surging anti-Americanism is damaging iconic brands. To survive, firms must swap patriotic ads for authentic local partnership.

A wellness company is calling out the supplement industry, claiming many popular shilajit gummies are ineffective, candy-like products. Here's what's real.

The clean-energy firm is commercializing its tech, securing a 10-year fuel deal in Portugal and deploying rail turbines as it seeks greater market access.

A new poll shows Iowans are furious over rising medical bills. With bipartisan anger mounting, the issue could reshape the 2026 political landscape.

Following a five-year transformation, engineering firm Pond & Company enters a new era under Arlington Capital, signaling strong PE interest in infrastructure.

Oriental Culture Holding celebrates its 5th Nasdaq anniversary with a special dividend, but a look at its finances reveals a more complex picture.

As the SF Zoo faces a financial crisis, a poll reveals overwhelming public support for a bold plan to replace it with a $350M conservation-focused EcoPark.

Austrian firm AOP Health secures nationwide access for its rapid heart rate drug, Rapiblyk™, by partnering with top US distributors. What does this mean for critical care?

After a strategic pivot reverses a year of decline, Allurion's preliminary results show new growth. All eyes are now on the FDA for its 'procedureless' gastric balloon.

Erasca reports promising early data for its pan-RAS inhibitor, ERAS-0015, showing tumor shrinkage at low doses and shaking up the competitive landscape.

A new White House executive order and a proposed $1.5T budget are shaking up defense contracting. Here's how agile firms like Volatus are set to win.

KEY Investment Partners acquires BellRock Brands' portfolio out of receivership, launching MM Brands with Joe Bayern to lead a wellness-focused revival.

One year after devastating wildfires, many uninsured seniors are still displaced. Habitat LA's volunteer event highlights the long, arduous road to recovery.

As Triumph Financial preps its Q4 2025 results, investors watch to see if its tech investments can deliver on high growth expectations amid a complex freight market.

Amid a nationwide blackout, Iran selectively restores internet for universities, a move experts call a new phase of state control and surveillance.

The Chinese auto-tech firm regained Nasdaq's minimum bid price but still faces delisting over its low market value, setting up a critical hearing.